<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34340958</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2253-8089</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Revista espanola de medicina nuclear e imagen molecular</Title><ISOAbbreviation>Rev Esp Med Nucl Imagen Mol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle><sup>18</sup>F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae.</ArticleTitle><Pagination><StartPage>299</StartPage><EndPage>309</EndPage><MedlinePgn>299-309</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.remnie.2021.07.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2253-8089(21)00126-9</ELocationID><Abstract><AbstractText>In recent months, much of the scientific efforts have focused on research on SARSCoV-2 infection and its consequences in humans. Still, many aspects remain unknown. It is known that the damage caused by SARS-CoV-2 is multifactorial and that its extension goes beyond lung inflammation and the acute phase, with the appearance of numerous complications and sequelae. To date, knowledge about the usefulness of <sup>18</sup>F-FDG-PET/CT in the acute phase has been limited to the incidental detection of SARS-CoV-2 unsuspected pneumonia. Recent studies have been appearing collecting the findings of <sup>18</sup>F-FDG-PET/CT in long COVID-19 or persistent COVID-19 state as well as the alterations caused after mass vaccination of the population in the metabolic studies. This work aims to review the existing literature focusing on these three issues and to briefly present our own preliminary experience.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedad Espa&#xf1;ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Alfonso</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. Electronic address: brodrigueza@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz Sol&#xed;s</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Nuclear del Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Hern&#xe1;ndez</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pintos Pascual</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguado Ib&#xe1;&#xf1;ez</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salas Ant&#xf3;n</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Anatom&#xed;a Patol&#xf3;gica del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Med Nucl Imagen Mol (Engl Ed)</MedlineTA><NlmUniqueID>101770941</NlmUniqueID><ISSNLinking>2253-8089</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="Y">Positron Emission Tomography Computed Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="Y">Radiopharmaceuticals</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Durante los &#xfa;ltimos meses gran parte de los esfuerzos cient&#xed;ficos se han centrado en la investigaci&#xf3;n sobre el SARS-CoV-2 y las consecuencias de su infecci&#xf3;n en humanos. Aun as&#xed;, muchos aspectos siguen siendo desconocidos. Se sabe que la afectaci&#xf3;n por SARS-CoV-2 es multifactorial y que su extensi&#xf3;n va m&#xe1;s all&#xe1; del da&#xf1;o pulmonar y del momento agudo, con aparici&#xf3;n de numerosas de complicaciones y secuelas. El conocimiento de la utilidad de la <sup>18</sup>F-FDG-PET/TC en el momento agudo se ha limitado, hasta la fecha, a la detecci&#xf3;n incidental de afectaci&#xf3;n pulmonar por SARS-CoV-2. En los &#xfa;ltimos meses han ido apareciendo trabajos que recogen los hallazgos de la <sup>18</sup>F-FDG-PET/TC en el estado post-COVID, as&#xed;como las alteraciones provocadas en la imagen metab&#xf3;lica tras la vacunaci&#xf3;n masiva de la poblaci&#xf3;n. Este trabajo pretende revisar la literatura existente sobre estas tres cuestiones y exponer de manera breve la experiencia preliminar propia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedad Espa&#xf1;ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">(18)F-FDG-PET/CT</Keyword><Keyword MajorTopicYN="N">(18)F-FDG-PET/TC</Keyword><Keyword MajorTopicYN="N">COVID-19 persistente</Keyword><Keyword MajorTopicYN="N">Inflamaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword><Keyword MajorTopicYN="N">Vacuna</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34340958</ArticleId><ArticleId IdType="pmc">PMC8316133</ArticleId><ArticleId IdType="doi">10.1016/j.remnie.2021.07.005</ArticleId><ArticleId IdType="pii">S2253-8089(21)00126-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [Internet]. [cited 2021 May 31]. Available from: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., Pramanik B.K., Kirsch C., Kuzniecky R.I. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar-Oromieh A., Prosch H., Schaefer-Prokop C., Bohn K.P., Alberts I., Mingels C. A comprehensive review of imaging findings in COVID-19 &#x2014; status in early 2021. Eur J Nucl Med Mol Imaging. 2021;48:2500&#x2013;2524. doi: 10.1007/s00259-021-05375-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05375-3</ArticleId><ArticleId IdType="pmc">PMC8087891</ArticleId><ArticleId IdType="pubmed">33932183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-P&#xe9;rez G.C., O&#xf1;ate Miranda M., Fern&#xe1;ndez-Rodr&#xed;guez P., Velasco Casares M., Corral de la Calle M., Franco L&#xf3;pez &#xc1;. SARS-CoV-2: c&#xf3;mo es, c&#xf3;mo act&#xfa;a y c&#xf3;mo se expresa en la imagen. Radiologia. 2020;63:115&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671642</ArticleId><ArticleId IdType="pubmed">33309398</ArticleId></ArticleIdList></Reference><Reference><Citation>Revzin M.V., Raza S., Warshawsky R., D&#x2019;agostino C., Srivastava N.C., Bader A.S. Multisystem imaging manifestations of covid-19, part 1: Viral pathogenesis and pulmonary and vascular system complications. Radiographics. 2020;40:1574&#x2013;1599. doi: 10.1148/rg.2020200149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2020200149</ArticleId><ArticleId IdType="pmc">PMC7534458</ArticleId><ArticleId IdType="pubmed">33001783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zirui Tay M., Meng Poh C., R&#xe9;nia L., MacAry P.A., Ng P.L.F. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Inmunol. 2020;20:363&#x2013;374. doi: 10.1038/nature01096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01096</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;15:1&#x2013;14. doi: 10.1007/s11239-020-02134-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02134-3</ArticleId><ArticleId IdType="pmc">PMC7225095</ArticleId><ArticleId IdType="pubmed">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Behzad S., Aghaghazvini L., Radmard A.R., Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging. 2020;66:35&#x2013;41. doi: 10.1016/j.clinimag.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7233216</ArticleId><ArticleId IdType="pubmed">32425338</ArticleId></ArticleIdList></Reference><Reference><Citation>Katal S., Balakrishnan S., Gholamrezanezhad A. Neuroimaging and neurologic findings in COVID-19 and other coronavirus infections: a systematic review in 116 patients. J Neuroradiol. 2021;48:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320684</ArticleId><ArticleId IdType="pubmed">32603770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R., Qiu Y., He J.S., Tan J.Y., Li X.H., Liang J. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:667&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C., Joost Wiersinga W. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Landete P., Loaiza C.A.Q., Aldave-Orzaiz B., Mu&#xf1;iz S.H., Maldonado A., Zamora E. Clinical features and radiological manifestations of COVID-19 disease. World J Radiol. 2021;12:247&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745468</ArticleId><ArticleId IdType="pubmed">33362916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields B.K.K., Demirjian N.L., Dadgar H., Gholamrezanezhad A. Imaging of COVID-19: CT, MRI, and PET. Semin Nucl Med. 2021;51(4):312&#x2013;320. doi: 10.1053/j.semnuclmed.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7703471</ArticleId><ArticleId IdType="pubmed">33288215</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson S., Kay F.U., Abbara S., Bhalla S., Chung J.H., Chung M. Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2001;2020:e52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233447</ArticleId><ArticleId IdType="pubmed">33778571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Wang L., Ben S. Meta-analysis of chest CT features of patients with COVID-19 pneumonia. J Med Virol. 2021;93:241&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361361</ArticleId><ArticleId IdType="pubmed">32579236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin G.D., Ryerson C.J., Haramati L.B., Sverzellati N., Kanne J.P., Raoof S. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest. 2020;158:106&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138384</ArticleId><ArticleId IdType="pubmed">32275978</ArticleId></ArticleIdList></Reference><Reference><Citation>Recomendaciones SEIMC para el manejo cl&#xed;nico de pacientes con COVID-19. [Internet]. [cited 2021 Jun 23]. Available from: https://covid19.seimc.org/index.php/recomendaciones-de-tratamiento/.</Citation></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines (Basel) 2021;9:497. doi: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xed;a Cl&#xed;nica para la atenci&#xf3;n al paciente Long COVID/COVIDPersistente [Internet] [consultado 23 Jun 2021]. Available from: https://www.sen.es/attachments/article/2906/GUI%CC%81A%20CLINICACOVID%20Persistente.pdf.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Internet] 2021 2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., Court C.A.&#x2019;, Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y., Lei L., Chen Y., Zhang W. The potential added value of FDG PET/CT for COVID-19 pneumonia. Eur J Nucl Med Mol Imaging. 2020;47(7):1634&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087529</ArticleId><ArticleId IdType="pubmed">32198615</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitanio S., Nordin A.J., Noraini A.R., Rossetti C. PET/CT in nononcological lung diseases: current applications and future perspectives. Eur Respir Rev. 2016;25:247&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9487216</ArticleId><ArticleId IdType="pubmed">27581824</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Langer R.D., Larsson S.G. Middle East respiratory syndrome coronavirus: what does a radiologist need to know? Am J Roentgenol. 2016;206:1193&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pubmed">26998804</ArticleId></ArticleIdList></Reference><Reference><Citation>Chefer S., Thomasson D., Seidel J., Reba R.C., Bohannon J.K., Lackemeyer M.G. Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge. EJNMMI Res. 2015;5:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646887</ArticleId><ArticleId IdType="pubmed">26573211</ArticleId></ArticleIdList></Reference><Reference><Citation>Haagmans B.L., van den Brand J.M.A., Provacia L.B., Raj V.S., Stittelaar K.J., Getu S. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J Virol. 2015;89:6131&#x2013;6135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442453</ArticleId><ArticleId IdType="pubmed">25810539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace M., Pyzalski R., Horejsh D., Brown C., Djavani M., Lu Y. Whole body positron emission tomography imaging of activated lymphoi tissues during acute simian-human immunodeficiency virus 89.6PD infection in Rhesus Macaques. Virology. 2000;274:255&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">10964769</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberts I., Vollnberg B., Sachpekidis C., Mingels C., Weidner S., Afshar-Oromieh A. Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT&#x2014;potential insights. Eur J Nucl Med Mol Imaging. 2020;47:2068&#x2013;2069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244259</ArticleId><ArticleId IdType="pubmed">32444898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakfie-Corieh C.G., Ferrando-Castagnetto F., Blanes Garcia A.M., Garcia-Esquinas M.G., Ortega Candil A., Rodriguez Rey C. Incidental findings suggestive of COVID-19 pneumonia in oncological patients undergoing 18F-FDG PET/CT studies: association between metabolic and structural lung changes. J Nucl Med. 2021 doi: 10.2967/jnumed.121.261915. Jun 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.261915</ArticleId><ArticleId IdType="pmc">PMC8805775</ArticleId><ArticleId IdType="pubmed">34088776</ArticleId></ArticleIdList></Reference><Reference><Citation>Albano D., Bertagna F., Bertoli M., Bosio G., Lucchini S., Motta F. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61:632&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">32238429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucientes Rasilla J., Jimeno Pernett R., Cardona Arboni&#xe9;s J. Diagnosis of COVID-19 pneumonia in asymptomatic patients after an oncological PET/CT. Rev Esp Med Nucl Imagen Mol. 2020;39:299&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229936</ArticleId><ArticleId IdType="pubmed">32426303</ArticleId></ArticleIdList></Reference><Reference><Citation>Albano D., Bertagna F., Alongi P., Baldari S., Baldoncini A., Bartolomei M. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study. Eur J Nucl Med Mol Imaging. 2021;9:1&#x2013;12. doi: 10.1007/s00259-021-05219-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05219-0</ArticleId><ArticleId IdType="pmc">PMC7871520</ArticleId><ArticleId IdType="pubmed">33560453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiee F., Keshavarz P., Katal S., Assadi M., Nejati S.F., Ebrahimian Sadabad F. Coronavirus disease 2019 (COVID-19) in molecular imaging: a systematic review of incidental detection of SARS-CoV-2 pneumonia on PET studies. Semin Nucl Med. 2021;51:178&#x2013;191. doi: 10.1053/j.semnuclmed.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7598766</ArticleId><ArticleId IdType="pubmed">33509374</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Liu F., Yen T.C., Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging. 2020;47:1281&#x2013;1286. doi: 10.1007/s00259-020-04734-w. Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04734-w</ArticleId><ArticleId IdType="pmc">PMC7080035</ArticleId><ArticleId IdType="pubmed">32088847</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;tje S., Marinova M., K&#xfc;tting D., Attenberger U., Essler M., Bundschuh R.A. Nuclear medicine in SARS-CoV-2 pandemia:18 F-FDG-PET/CT to visualize COVID-19. NuklearMedizin. 2020;59:276&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">32259853</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz M., Chironi G., Claessens Y.E., Farhad R.L., Rouquette I., Serrano B. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome. Eur J Nucl Med Mol Imaging. 2021;48:260&#x2013;268. doi: 10.1007/s00259-020-04968-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04968-8</ArticleId><ArticleId IdType="pmc">PMC7382557</ArticleId><ArticleId IdType="pubmed">32712702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Xu J., Chen L., Fu C., Kang Y., Zhang W. Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging. 2021;48:2531&#x2013;2542. doi: 10.1007/s00259-020-05083-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05083-4</ArticleId><ArticleId IdType="pmc">PMC7794623</ArticleId><ArticleId IdType="pubmed">33420914</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021:1&#x2013;11. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri L., Moss S., Khan F., Chi W., Xia J., Robinson K. Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: a systematic review and meta-analysis. medRxiv [Internet] 2021 doi: 10.1101/2021.03.15.21253593. March 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.15.21253593</ArticleId><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>John A.E., Joseph C., Jenkins G., Tatler A.L. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021 doi: 10.1111/imr.12977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12977</ArticleId><ArticleId IdType="pmc">PMC8237078</ArticleId><ArticleId IdType="pubmed">34028807</ArticleId></ArticleIdList></Reference><Reference><Citation>Win T., Screaton N.J., Porter J.C., Ganeshan B., Maher T.M., Fraioli F. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF) Eur J Nucl Med Mol Imaging. 2018;45:806&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5978900</ArticleId><ArticleId IdType="pubmed">29335764</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhakal B.P., Sweitzer N.K., Indik J.H., Acharya D., William P. SARS-CoV-2 infection and cardiovascular disease: COVID-19 Heart. Heart Lung Cir. 2020;29:973&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274628</ArticleId><ArticleId IdType="pubmed">32601020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghvi S.K., Schwarzman L.S., Nazir N.T. Cardiac MRI and myocardial injury in COVID-19: diagnosis, risk stratification and prognosis. Diagnostics. 2021;11:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830889</ArticleId><ArticleId IdType="pubmed">33467705</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshdy A., Zaher S., Fayed H., Coghlan J.G. COVID-19 and the heart: a systematic review of cardiac autopsies. Front Cardiovasc Med. 2021;7 doi: 10.3389/fcvm.2020.626975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.626975</ArticleId><ArticleId IdType="pmc">PMC7876291</ArticleId><ArticleId IdType="pubmed">33585586</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballeros Lam M., de la Fuente Villena A., Hern&#xe1;ndez Hern&#xe1;ndez A., Garc&#xed;a de Y&#xe9;benes M., Bastarrika Alema&#xf1; G. Cardiac magnetic resonance characterization of COVID-19 myocarditis. Rev Espa&#xf1;ola Cardiol. 2020;73:863&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334914</ArticleId><ArticleId IdType="pubmed">32694081</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudski L., Januzzi J.L., Rigolin V.H., Bohula E.A., Blankstein R., Patel A.R. Multimodality imaging in evaluation of cardiovascular complications in patients with COVID-19. JACC. 2020;76:1345&#x2013;1357. doi: 10.1016/j.jacc.2020.06.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.080</ArticleId><ArticleId IdType="pmc">PMC7375789</ArticleId><ArticleId IdType="pubmed">32710927</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval X., Le Moing V., Tubiana S., Esposito-Far&#xe8;se M., Ilic-Habensus E., Leclercq F. Impact of systematic whole-body 18F-Fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa666. Jun 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa666</ArticleId><ArticleId IdType="pubmed">32488236</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R., Barreiro-Perez M., Martin-Garcia A., Almeida J., Villacorta E., Perez-Pons A. Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv [Internet] 2020 doi: 10.1101/2020.07.12.20151316. Jul 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkbride R.R., Rawal B., Mirsadraee S., Galperin-Aizenberg M., Wechalekar K., Ridge C.A. Imaging of cardiac infections: a comprehensive review and investigation flowchart for diagnostic workup. J Thorac Imaging. 2020 doi: 10.1097/RTI.0000000000000552. Aug 25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000552</ArticleId><ArticleId IdType="pubmed">32852420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonthaitawee P., Beanlands R.S., Chen W., Dorbala S., Miller E.J., Murthy V.L. Joint SNMMI&#x2013;ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pubmed">28770463</ArticleId></ArticleIdList></Reference><Reference><Citation>Satapathy S., Kumar R., Kavanal A.J., Subramanian Krishnaraju V., Ramachandran A., Deo P. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): role of 18 F-FDG PET/CT to assess myocardial involvement. J Nucl Cardiol. 2021:1&#x2013;2. doi: 10.1007/s12350-021-02540-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-021-02540-x</ArticleId><ArticleId IdType="pmc">PMC7901863</ArticleId><ArticleId IdType="pubmed">33624189</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S.R., Shah A.S.V., Ombati K.O., Nganga E., Gitau S., Makhdomi K. CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) BMC Cardiovasc Disord. 2021;21:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106368</ArticleId><ArticleId IdType="pubmed">33964872</ArticleId></ArticleIdList></Reference><Reference><Citation>Harisankar C.N.B., Mittal B.R., Agrawal K.L., Abrar M.L., Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol. 2011;18:926&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">21732228</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Steardo L., Zorec R., Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. 2020;229</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228251</ArticleId><ArticleId IdType="pubmed">32223077</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Garg A., Sapra H., Gurnani A., Kakkar G., Khatib K.I. Pathophysiological mechanisms and neurological manifestations in COVID-19. Indian J Crit Care Med. 2020;24:975&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689109</ArticleId><ArticleId IdType="pubmed">33281325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridwell R., Long B., Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38 doi: 10.1016/j.ajem.2020.05.024. 1549.e3&#x2013;1549.e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.05.024</ArticleId><ArticleId IdType="pmc">PMC7229718</ArticleId><ArticleId IdType="pubmed">32425321</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A., Garc&#xed;a-Garc&#xed;a J. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95:e1060&#x2013;e1070. doi: 10.1212/WNL.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., De S&#xe8;ze J., Ferr&#xe9; J.C., Maamar A., Carsin-Nicol B. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297:E242&#x2013;E251. doi: 10.1148/radiol.2020202222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K.S., Nobili F. Is the frontal lobe the primary target of SARS-CoV-2? J Alzheimers Dis. 2021;81:75&#x2013;81. doi: 10.3233/JAD-210008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210008</ArticleId><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme C., Paccoud O., Kas A., Hesters A., Bombois S., Shambrook P. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020;27:2651&#x2013;2657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461074</ArticleId><ArticleId IdType="pubmed">32881133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., Soret M., Pyatigoskaya N., Habert M.O., Hesters A., Le Guennec L. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 2021;48:2543&#x2013;2557. doi: 10.1007/s00259-020-05178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05178-y</ArticleId><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijiala S., Epiney J.-B., J&#xf6;hr J., Pincherle A., Meyer M.M., Du Pasquier R. Case report: behavioral unresponsiveness in acute COVID-19 patients: the utility of the motor behavior tool-revised and 18F-FDG PET/CT. Front Neurol. 2021;12:659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119781</ArticleId><ArticleId IdType="pubmed">33995248</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi-Galougahi M., Yousefi-Koma A., Bakhshayeshkaram M., Raad N., Haseli S. 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol. 2020;27:1042&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196385</ArticleId><ArticleId IdType="pubmed">32386948</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesen M., Trotta N., Noel A., Coolen T., Fayad G., Leurkin-Sterk G. Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging. 2021;48:1890&#x2013;1901. doi: 10.1007/s00259-020-05154-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05154-6</ArticleId><ArticleId IdType="pmc">PMC7781559</ArticleId><ArticleId IdType="pubmed">33398411</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Napoli M. Di, Biller J., Siegler J.E., Shekhar R., Mccullough L.D. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236.379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-Guerrero A., Laespada-Garc&#xed;a M.I., G&#xf3;mez-Grande A., Ruiz-Ortiz M., Blanco-Palmero V.A., Azcarate-Diaz F.J. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020;95:e2109&#x2013;e2118. doi: 10.1212/WNL.0000000000010282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010282</ArticleId><ArticleId IdType="pubmed">32641525</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021:1&#x2013;11. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control&#x202f;&#x202f;study. Eur J Nucl Med Mol Imaging. 2021:1&#x2013;11. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana I.C., Souza D.G., Pellerin L., Souza D.G.O., Zimmer E.R. About the source and consequences of 18 F-FDG brain PET hypometabolism in short and long COVID-19. Eur J Nucl Med Mol Imaging. 2021:1&#x2013;2. doi: 10.1007/s00259-021-05342-y. Apr 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05342-y</ArticleId><ArticleId IdType="pmc">PMC8019399</ArticleId><ArticleId IdType="pubmed">33813593</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanella L., Ruggeri R.M., Petranovi&#x107; Ov&#x10d;ari&#x10d;ek P., Campenni A., Treglia G., Deandreis D. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists [Internet] Eur J Nucl Med Mol Imaging. 2021;48:1719&#x2013;1723. doi: 10.1007/s00259-021-05316-0/.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05316-0/</ArticleId><ArticleId IdType="pubmed">33765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Eifer M., Eshet Y. Imaging of COVID-19 Vaccination at FDG PET/CT. Radiology. 2021;299 doi: 10.1148/radiol.2020210030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020210030</ArticleId><ArticleId IdType="pmc">PMC7845454</ArticleId><ArticleId IdType="pubmed">33507123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen D., Krauthammer S.H., Wolf I., Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. 2021;48:1854&#x2013;1863. doi: 10.1007/s00259-021-05314-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05314-2</ArticleId><ArticleId IdType="pmc">PMC8003894</ArticleId><ArticleId IdType="pubmed">33774684</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg J., Thomas A., Iravani A., Steinberg J. 18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine. Lancet. 2021;397(10279) doi: 10.1016/S0140-6736(21)00464-00465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00464-00465</ArticleId><ArticleId IdType="pmc">PMC7972305</ArticleId><ArticleId IdType="pubmed">33705696</ArticleId></ArticleIdList></Reference><Reference><Citation>Eifer M., Tau N., Alhoubani Y., Kanana N., Domachevsky L., Shams J. Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake. J Nucl Med. 2021 doi: 10.2967/jnumed.121.262194.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262194</ArticleId><ArticleId IdType="pmc">PMC8717182</ArticleId><ArticleId IdType="pubmed">33893188</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh L.J., Bankier A.A., Vijayaraghavan G.R., Licho R., Rosen M.P. COVID-19 vaccination-related uptake on FDG PET/CT: an emerging dilemma and suggestions for management. Am J Roentgenol. 2021 doi: 10.2214/AJR.21.25728. Mar 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.21.25728</ArticleId><ArticleId IdType="pubmed">33646823</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshet Y., Tau N., Alhoubani Y., Kanana N., Domachevsky L., Eifer M. Prevalence of increased FDG PET/CT axillary lymph node uptake beyond 6 weeks after mRNA COVID-19 vaccination. Radiology. 2021 doi: 10.1148/radiol.2021210886. Apr;27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210886</ArticleId><ArticleId IdType="pmc">PMC8082565</ArticleId><ArticleId IdType="pubmed">33904778</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.H., Shah S., Groves A.M., Wan S., Malhotra A. The challenge of staging breast cancer with PET/CT in the era of COVID vaccination. Clin Nucl Med. 2021 doi: 10.1097/RLU.0000000000003683. Apr 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000003683</ArticleId><ArticleId IdType="pmc">PMC8575097</ArticleId><ArticleId IdType="pubmed">33795590</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder D.G., Jang S., Johnson D.R., Takahashi H., Navin P.J., Broski S.M. Frequency and characteristics of nodal and deltoid FDG and 11C-choline uptake on PET imaging performed after COVID-19 vaccination. AJR Am J Roentgenol. 2021 https://www.ajronline.org/doi/10.2214/AJR.21.25928 May 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.21.25928</ArticleId><ArticleId IdType="pubmed">34009000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>